Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 07, 2019

SELL
$63.59 - $78.71 $197,637 - $244,630
-3,108 Closed
0 $0
Q1 2019

Apr 30, 2019

BUY
$50.75 - $80.54 $157,731 - $250,318
3,108 New
3,108 $244,000
Q4 2018

Feb 12, 2019

SELL
$52.18 - $67.93 $174,333 - $226,954
-3,341 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$38.13 - $68.37 $127,392 - $228,424
3,341 New
3,341 $217,000
Q2 2018

Aug 14, 2018

SELL
$27.62 - $44.51 $240,183 - $387,058
-8,696 Closed
0 $0
Q1 2018

May 10, 2018

BUY
$26.05 - $34.5 $226,530 - $300,012
8,696 New
8,696 $268,000
Q4 2017

Feb 09, 2018

SELL
$24.5 - $36.01 $203,350 - $298,883
-8,300 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$31.26 - $42.03 $259,458 - $348,849
8,300
8,300 $274,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.45B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.